https://heliusmedical.com/index.php/newsroom/news-release/2020/414-eliusedicalechnologiesncnnouncesasranted20200512110500
Helius Medical Technologies, Inc. Announces FDA Has Granted the PoNS Device Breakthrough Device Designation for the Treatment of Gait Deficits Due to Symptoms of Multiple Sclerosis